GB
Genesis Bioventures Inc Stock: price and insider trades · United States
No insider purchase over the last 90 days. The latest, by FG2 Advisors, LLC, was filed 19 Nov 2007.
Genesis Bioventures Inc: what insiders have been doing
Genesis Bioventures Inc is a listed company. Its directors and officers file their transactions with SEC (Form 4). The past year has been quiet: not a single insider filing for Genesis Bioventures Inc. The previous disclosure was published on 12 September 2008.
Our records for Genesis Bioventures Inc go back to 2006, with 4 purchases and 5 sales on the open market in total.
This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Insider Decl.
12
Thresholds
n/a
Buy Volume
€1,774
4 ops. · all time
Sell Volume
€3,362
5 ops. · all time
Last declaration on 12 September 2008
Declarations12 total
- 5,546,998 shares@ US$0.05Common StockSEC:0001420835-08-000001:0
- 750,000 shares0Common Stock (par value $0.0001)SEC:0001012975-08-000151:0
- 11,311,350 shares@ US$0.028Common Stock (par value $0.0001)SEC:0001012975-08-000151:1
- 50,000 shares@ US$0.05Common Stock (par value $0.0001)SEC:0001181431-07-070568:0Canonical exit: 20 Dec 2007 (T+90)
- 5,000 shares@ US$0.125Common StockSEC:0001077048-07-000210:0
- 10,000 shares@ US$0.10Common StockSEC:0001077048-07-000210:1
- 5,000 shares@ US$0.11Common StockSEC:0001077048-07-000210:2
- 10,000 shares@ US$0.12Common StockSEC:0001077048-07-000210:3
- 10,000 shares@ US$0.12Common StockSEC:0001077048-07-000210:4
- 2,213,281 sharesCOMMON SHARESSEC:0001276362-06-000003:0Canonical exit: 16 May 2006 (T+90)
- 2,023,374 sharesCOMMON SHARESSEC:0001276365-06-000009:0Canonical exit: 14 May 2006 (T+90)
- 1,299,186 sharesCOMMON SHARESSEC:0001276365-06-000008:0Canonical exit: 14 May 2006 (T+90)
12 of 12 declarations
